News
Opinion
Resources
Webcasts
Podcasts
White Papers
Events
E-Books
Associations and Organizations
Conferences
Conference Listing
Brand Insights
Subscribe
Advertise
Spotlight
Companion Diagnostics
Digital Biomarkers
Digital Endpoints
Digital Therapeutics
Drug-Device Combinations
Medical Devices, Class II and Class III
RWE
Software as a Medical Device
Topic
AI
Clinical Care
Cybersecurity
Data Science
Remote Patient Monitoring
Payers
Strategy
News
Opinion
Resources
Webcasts
Podcasts
White Papers
Events
E-Books
Associations and Organizations
Conferences
Conference Listing
Brand Insights
Subscribe
Advertise
Advertisement
AI
| Academic Research
| Clinical Care
| Clinical Trials
| Commercialization
| Companion Diagnostics
| Cybersecurity
| Data Science
| Device Development
| Digital Biomarkers
| Digital Endpoints
| Digital Therapeutics
| Drug-Device Combinations
| Ethics
| Medical Devices (Class II and Class III)
| Patient Engagement
| Payers
| Profiles/Q&A
| RWE
| Regulatory
| Remote Patient Monitoring
| SaMD
| Strategy
| Studies/Published Research
| Virtual Reality
View All >>
AI
Academic Research
Clinical Care
Clinical Trials
Commercialization
Companion Diagnostics
Cybersecurity
Data Science
Device Development
Digital Biomarkers
Digital Endpoints
Digital Therapeutics
Drug-Device Combinations
Ethics
Medical Devices (Class II and Class III)
Patient Engagement
Payers
Profiles/Q&A
RWE
Regulatory
Remote Patient Monitoring
SaMD
Strategy
Studies/Published Research
Virtual Reality
SPOTLIGHT
-
Companion Diagnostics
| Digital Biomarkers
| Digital Endpoints
| Digital Therapeutics
| Drug-Device Combinations
| Medical Devices, Class II and Class III
| RWE
| Software as a Medical Device
Michaela Miller, Vice President, Technology & Analytics, IQVIA
home
/ authors
/ michaela-miller-vice-president-technology-analytics-iqvia
Articles
Advertisement
MedTech is Prioritizing Digital Engagement in Omnichannel Strategies
December 1st 2023
